Strongbone Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Strongbone General Information


Developer of treatments for osteoporosis, rheumatoid arthritis and peri-implantitis. The company develops treatments for diseases that are caused by bone degrading cells called osteoclasts namely osteoporosis, rheumatoid arthritis and peri-implantitis.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • Erik Dahlbergsgatan 11A
  • 2nd Floor
  • 411 26 Gothenburg
  • Sweden
+46 031-786 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Strongbone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 27-Mar-2013 Completed Startup
To view Strongbone’s complete valuation and funding history, request access »

Strongbone Executive Team (2)

Name Title Board Seat Contact Info
Anders Grubb MD Co-Founder
Ulf Lerner Co-Founder
To view Strongbone’s complete executive team members history, request access »

Strongbone Board Members (1)

Name Representing Role Since
Håkan Thorbjörnsson GU Ventures Chairman 000 0000
To view Strongbone’s complete board members history, request access »

Strongbone Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
GU Ventures Accelerator/Incubator Minority 000 0000 000000 0
To view Strongbone’s complete investors history, request access »